FDA Adverse Event Malfunction Summary report: N

FINELINE II

MDR report key: 2052742 · Received April 13, 2011

Report

Report Number
2124215-2011-03575
Event Type
Malfunction
Date Received
April 13, 2011
Date of Event
May 1, 2010
Report Date
February 24, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
PMA / PMN Number
P960004
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE ASSOCIATED DEVICE WAS REPROGRAMMED FROM DDD MODE TO AAI. THE LEAD REMAINS IMPLANTED. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT BACK IN (B)(6) 2010, THIS RIGHT VENTRICULAR (RV) LEAD DISLODGED. NO ADVERSE PATIENT EFFECTS WERE REPORTED. THE DISLODGEMENT DID NOT AFFECT PACING IN THE VENTRICLE AS THE PATIENT HAS SICK SINUS SYNDROME WITH GOOD AV CONDUCTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FINELINE II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4457

Patients

Seq Age Sex Outcome Treatment
1 Other